Primerica, Inc.

Primerica, Inc. is a U.S.-based financial services company focused on middle-income households in the United States and Canada. Through an independent sales force, it underwrites term life insurance and distributes mutual funds, annuities, managed investments, and other financial products through its insurance, broker-dealer, and investment subsidiaries.

22,8 %

+6,6 %

— Primerica, Inc.
%
Term Life Insurance45% Underwritten life insurance protection sold to middle-income households in the U.S. and Canada.
Investment and Savings Products35% Mutual funds, annuities, and managed investments distributed through the sales force.
Corporate and Other Distributed Products20% Closed blocks, prepaid legal services, mortgage originations, and other third-party products.

Primerica serves middle-income households that want straightforward protection and savings products sold through...

  • Middle-income householdsprimary

    Buy term life insurance, mutual funds, annuities, and related financial products for protection and savings.

  • Life insurance clientsprimary

    Purchase term coverage underwritten by Primerica Life and NBLIC to protect family income needs.

  • Investment and savings clientsprimary

    Buy mutual funds, managed investments, and annuities distributed through the sales force.

  • Independent sales representativesprimary

    Sell Primerica products and recruit new representatives, supporting the distribution model.

Primerica conducts core business in the United States and Canada, with underwriting, broker-dealer, and fund-management...

  • •Core operations are in the United States and Canada
  • •U.S. subsidiaries include life insurance and investment entities
  • •Canadian subsidiaries underwrite life insurance and distribute funds
  • •Demand is tied to U.S. and Canadian consumer confidence
  • •Currency and regulatory differences affect reported results

Primerica’s strategy centers on expanding its independent sales force, improving digital tools for representatives and...

01
Expand the independent sales forceshort-term

Distribution capacity is central to reaching middle-income households cost-effectively.

02
Improve digital engagementmedium-term

Better digital tools support connected conversations and sales productivity.

03
Broaden product penetrationmedium-term

Serving more financial needs increases client value and revenue opportunities.

Primerica faces regulatory, competitive, and market risks tied to its insurance and securities distribution model...

high

Regulatory and policy changes

The company operates under U.S. and Canadian insurance, securities, privacy, and AML rules.

Scope
Insurance and securities subsidiaries
Materiality
high
high

Competitive pressure

Primerica competes with insurers, broker-dealers, banks, RIAs, and direct channels.

Scope
Term life, mutual funds, annuities, and managed investments
Materiality
high
high

Recruiting and retention of representatives

The business model depends on a large independent sales force to generate sales.

Scope
Distribution network
Materiality
high
medium

Market and interest-rate sensitivity

Client demand for savings products and asset-based revenues moves with markets and rates.

Scope
Investment and savings products
Materiality
high
medium

Capital and statutory reserve requirements

Insurance subsidiaries must maintain regulatory capital and reserves in the U.S. and Canada.

Scope
Life insurance underwriting entities
Materiality
high
Deferred acquisition costs (DAC)
Life insurance profitability and expense recognition
Future policy benefit reserves
Insurance liabilities and earnings volatility
Reinsurance recoverables
Balance-sheet assets and credit exposure
Investment valuation
Net investment income and unrealized gains/losses

DYADIC INTERNATIONAL INC

DYAI · Biological Products, (No Diagnostic Substances)

Precipio, Inc.

PRPO · Laboratory Analytical Instruments

Dogecoin Cash, Inc.

DOGP · Services-Personal Services

Verrica Pharmaceuticals Inc.

VRCA · Pharmaceutical Preparations

BIOMERICA INC

BMRA · In Vitro & In Vivo Diagnostic Substances

IMMUNIC, INC.

IMUX · Pharmaceutical Preparations

: 29.4.2026